Invention Grant
US09279811B2 Methods and kits that identify tumors responsive to Src inhibitors 有权
识别对Src抑制剂有响应的肿瘤的方法和试剂盒

Methods and kits that identify tumors responsive to Src inhibitors
Abstract:
Disclosed herein are methods of predicting whether or not a subject will benefit from treatment with a Src inhibitor on the basis of the expression of one or more of Von Hippel Lindau (VHL), Src, PTP1B, pFAK, HIF-1α, and/or CA-IX in a tumor sample from the subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0